Queen’s University Belfast Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
University of Liverpool Featured PhD Programmes
University of Kent Featured PhD Programmes
University College London Featured PhD Programmes
"medicinal" AND "chemistr…×
10 miles

medicinal chemistry PhD Projects, Programs & Scholarships

We have 33 medicinal chemistry PhD Projects, Programs & Scholarships

  • "medicinal" AND "chemistry" ×
  • clear all
Order by 
Showing 1 to 10 of 33
  Biomolecular Science and Medicinal Chemistry Division PhD project: Proteases in the ubiquitin system – from molecular mechanisms to the development of novel inhibitors
  Dr I Dreveny
Applications accepted all year round
Ubiquitin is a posttranslational modifier that tags substrate proteins for degradation and regulates virtually all known cellular processes.
  Synthetic Medicinal Carbohydrate Chemistry PhD in the area of Glycomimetics.
  Dr P Murphy
Application Deadline: 1 April 2019
The successful candidate will work on a project concerned with the design and synthesis of glycomimetics. Specifically they will synthesize complex target molecules designed against various targets such as galectin-8 and siglec-8 involved in asthma and some forms of inflammation/cancer.
  Exploiting druggability host spots in protein phosphatase targets
  Dr L Tabernero, Prof D Procter, Dr S Butterworth
Applications accepted all year round
In the past years the use of virtual screening or computer-based screening of compound libraries against selected targets has expanded exponentially the boundaries of drug discovery.
  Development of new serine protease inhibitors by optimisation of rationally designed covalent S1 fragments
  Dr M Stocks, Dr J Emsley
Applications accepted all year round
The PhD studentship is an EPSRC Doctoral Training Partnership (https://epsrc.ukri.org/skills/students/dta/termsconds/) in collaboration with KalVista Pharmaceuticals a pharmaceutical company focused on the discovery, development, and commercialisation of small molecule protease inhibitors for diseases with significant unmet medical need.
  Structure based design of novel warheads for use in peptide-drug conjugates
  Dr S Butterworth, Dr A Tirella, Dr D Wiseman
Applications accepted all year round
Chronic Myelomonocytic Leukaemia (CMML) is an orphan disease defined by myeloid dysplasia, myeloproliferation and a malignant expansion of classical monocytes.
  Synthetic Organic Approaches for Covalent Inhibition of Protein-Protein
  Dr S Thompson
Applications accepted all year round
We are looking for an enthusiastic and well-organized student with an interest in applying the full range of synthetic organic chemistry methods to design and construct conformationally well-defined molecules (foldamers) that covalently recognise key elements of protein surfaces.
  EPSRC Centre for Doctoral Training in Molecular Sciences for Medicine - 4 year PhD Studentships
Applications are invited from suitably qualified graduates for fully funded 4-year PhD studentships in the area of Molecular Sciences for Medicine (MosMed) and will focus on unmet medical needs.
  EPSRC Centre for Doctoral Training in Molecular Sciences for Medicine - 4 year PhD Studentships
Applications are invited from suitably qualified graduates for fully funded 4-year PhD studentships in the area of Molecular Sciences for Medicine (MosMed) and will focus on unmet medical needs.
  PhD Studentship in MosMed CDT: Development of MRI scan methods to image inhaled fluorocarbon gases as biomarkers of lung structure and function
  Dr P Thelwall
Application Deadline: 12 April 2019
Number of awards. 1. Start date and duration. September 2019 for 4 years. Overview. Lung diseases are a leading cause of death, and new treatments are emerging.
  Precious metals in the fight against cancer
  Dr I Romero-Canelon
Applications accepted all year round
Platinum-based complexes, Cisplatin, Oxaliplatin and Carboplatin, are the most widely used chemotherapeutics, nonetheless there is a major unmet clinical need for new treatments that expand the range of treatable cancers and overcome inherent and acquired platinum resistance.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.